The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

28 Jun 2023 07:00

RNS Number : 1172E
Instem plc
28 June 2023
 

Instem plc("Instem" or the "Company")

 

Result of AGM 

 

Instem (AIM: INS.L), a leading provider of IT solutions to the global life sciences market, announces that at its Annual General Meeting held yesterday, all resolutions were duly passed. The results of the proxy voting position received in advance of the meeting are reported below:

 

No.

Resolution

For

% For

Against

% Against

Withheld

01

Reports and Accounts

12,896,645

100.00

0

0.00

91,158

02

Directors' Remuneration

8,031,684

61.94

4,935,969

38.06

150

03

Re-elect Mary Ruth Dolson

12,967,803

100.00

0

0.00

0

04

Re-elect David Gare

12,326,198

99.98

2,574

0.02

639,031

05

Elect N J Goldsmith

12,967,291

100.00

512

0.00

0

06

Re-elect R A Bandali

12,965,229

99.98

2,574

0.02

0

07

Re-elect M F McGoun

10,506,032

83.31

2,105,240

16.69

356,531

08

Re-elect P J Reason

12,967,291

100.00

512

0.00

0

09

Re-appoint Auditors

9,726,703

78.24

2,705,696

21.76

535,404

10

Auditors Remuneration

12,967,803

100.00

0

0.00

0

11

Allot Shares

12,064,426

93.03

903,377

6.97

0

12

Allot Equity Securities

12,063,876

93.03

903,927

6.97

0

13

Make Market Purchases

12,967,253

100.00

550

0.00

0

 

Notes:

 

· The full text of each of the resolutions is contained in the Notice of Annual General Meeting dated 2 June 2023, which is available on the Company's website at https://www.instem.com.

 

· Proxy appointments which gave discretion to the Chairman of the AGM have been included in the "For" total for the appropriate resolution.

 

· A "Withheld" vote is not a vote in law and is not counted in the calculation of the proportion of the votes cast "For" or "Against" a resolution.

 

· The issued share capital of the Company as at 27 June 2023 was 22,889,433 ordinary shares of 10p each. No shares are held in treasury.

 

In compliance with the QCA Code, the Board notes the percentage of votes cast against Resolutions 2 and 9 to approve the Directors' Remuneration Report and the re-appointment of the Company's Auditors. The Board has already engaged in discussions with certain of its major shareholders and continues to maintain a healthy dialogue with its investors. The Company will publish on its website in due course an explanation of any different action it plans on taking as a result of the vote.

 

For further information, please contact:

 

Instem plc

Via Walbrook

Phil Reason, CEO

Nigel Goldsmith, CFO

Singer Capital Markets (Nominated Adviser & Broker)

+44 (0) 20 7496 3000

Peter SteelAlex Bond

Oliver Platts

Stifel Nicolaus Europe Limited (Joint Broker)

+44 (0) 20 7710 7600

Ben Maddison

 

Richard Short

 

 

 

Walbrook Financial PR

+44 (0) 20 7933 8780

Tom Cooper

instem@walbrookpr.com

Nick Rome

Joe Walker

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSEMESWEDSEFM
Date   Source Headline
25th Feb 201610:17 amRNSHolding(s) in Company
23rd Feb 20161:32 pmRNSResult of General Meeting and Director Dealings
12th Feb 20167:00 amRNSInvestor Presentation
5th Feb 20164:47 pmRNSIssue of Equity and Total Voting Rights
4th Feb 20167:00 amRNSDirector/PDMR Shareholding
3rd Feb 20167:00 amRNSPlacing, Posting of Circular and Notice of GM
25th Jan 20167:00 amRNSInnovators & Investors Forum
13th Jan 20167:00 amRNSTrading Update
23rd Dec 20151:15 pmRNSDirector Shareholding and Other Holdings
8th Dec 20153:53 pmRNSIssue of Equity and Total Voting Rights
1st Dec 20157:00 amRNSLogos Earn Out, Issue of Equity and TVR
30th Nov 20155:59 pmRNSHolding(s) in Company
29th Sep 20157:00 amRNSHalf Yearly Report
6th Aug 201511:55 amRNSAdmission of Ordinary Shares
3rd Aug 20157:00 amRNSLogos Third Earn Out Payment & Total Voting Rights
30th Jul 20157:00 amRNSTrading Update and Notice of Interim Results
29th Jul 20157:01 amRNSGrants Under the Long Term Incentive Plan
23rd Jun 20157:00 amRNSInvestor Teach-in
21st May 20154:39 pmRNSHolding(s) in Company
19th May 20151:16 pmRNSResult of AGM
14th May 20157:00 amRNSInstem ALPHADAS Contract Wins
27th Apr 20159:16 amRNSPosting of Annual Report and Notice of AGM
30th Mar 20157:00 amRNSFinal Results
16th Mar 20157:00 amRNSNotice of Results
13th Feb 20157:00 amRNSPerceptive Instruments Earn Out Payment
27th Jan 20157:01 amRNSInnovators & Investors Forum (London)
12th Jan 20157:00 amRNSTrading Update and Notice of Results
23rd Dec 201411:52 amRNSHolding(s) in Company
18th Dec 20147:00 amRNSWIL Research Contract Extension
10th Nov 20147:00 amRNSCentrus-submit Contract Wins
24th Sep 20147:00 amRNSUnaudited Interim Results
5th Sep 20147:00 amRNSNotice of Results
13th Aug 201410:27 amRNSHolding(s) in Company
1st Aug 20147:00 amRNSLogos Second Earn Out Payment
16th Jul 20147:00 amRNSTwo contract wins in Asia-Pacific
21st May 201411:45 amRNSResult of AGM
1st May 20147:00 amRNSContract win
25th Apr 20147:00 amRNSPosting of Annual Report and Notice of AGM
26th Mar 20147:01 amRNSUS Government Contract Extension
26th Mar 20147:00 amRNSFinal Results
6th Mar 20147:00 amRNSNotice of Results
20th Feb 20147:00 amRNSThree-Year SaaS Contract with Leading Pharma
7th Feb 20141:05 pmRNSHolding(s) in Company
3rd Feb 20147:00 amRNSLogos Initial Earn Out Payment
8th Jan 20147:00 amRNSTrading Update and Notice of Results
22nd Nov 20137:00 amRNSAcquisition and Trading Update
9th Oct 20137:00 amRNSAppointment of VP Global Sales
25th Sep 20137:00 amRNSHalf Yearly Report
15th Aug 20137:00 amRNSNotice of Results
2nd Jul 20137:00 amRNSFirst Contract Win for Instem Clinical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.